Total Payments
$1,118
2024 Payments
$200.89
Companies
25
Transactions
48
Medicare Patients
4,081
Medicare Billing
$599,906
Payment Breakdown by Category
Food & Beverage$817.98 (73.2%)
Consulting$300.00 (26.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $817.98 | 46 | 73.2% |
| Consulting Fee | $300.00 | 2 | 26.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $168.31 | 2 | $0 (2023) |
| Alkermes, Inc. | $150.00 | 1 | $0 (2017) |
| Lundbeck LLC | $83.09 | 4 | $0 (2024) |
| ARGENX US, INC. | $67.38 | 2 | $0 (2023) |
| UCB, Inc. | $65.39 | 3 | $0 (2024) |
| Medtronic USA, Inc. | $62.03 | 5 | $0 (2019) |
| ABBVIE INC. | $59.35 | 3 | $0 (2024) |
| TG Therapeutics, Inc. | $58.59 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $55.54 | 3 | $0 (2024) |
| Medtronic, Inc. | $50.80 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $200.89 | 11 | Novartis Pharmaceuticals Corporation ($55.54) |
| 2023 | $315.01 | 9 | Biogen, Inc. ($150.00) |
| 2022 | $126.43 | 6 | Lundbeck LLC ($43.71) |
| 2021 | $196.08 | 10 | AbbVie Inc. ($39.13) |
| 2019 | $28.61 | 2 | PFIZER INC. ($17.21) |
| 2017 | $250.96 | 10 | Alkermes, Inc. ($150.00) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Drug Infusion Systems | ||||||
| 10/08/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: NEUROLOGY | ||||||
| 09/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Neurology | ||||||
| 07/23/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Immunology | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Neurology | ||||||
| 04/30/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Neurology | ||||||
| 02/09/2024 | Amylyx Pharmaceuticals, Inc. | RELYVRIO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $20.02 | General |
| 06/09/2023 | Biogen, Inc. | TYSABRI (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: Neurology | ||||||
| 05/10/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Altea (Device) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: MR - MRI | ||||||
| 04/18/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $12.72 | General |
| 04/04/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 03/30/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Adenosine A2A Receptors | ||||||
| 02/07/2023 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Immune | ||||||
| 02/04/2023 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Stents | ||||||
| 01/21/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Immunology | ||||||
| 11/08/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.41 | General |
| Category: NEUROLOGY | ||||||
| 10/05/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/10/2022 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Immunology | ||||||
| 07/08/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: NEUROLOGY | ||||||
| 04/19/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,005 | 9,178 | $425,732 | $163,859 |
| 2022 | 10 | 853 | 8,630 | $333,410 | $136,800 |
| 2021 | 13 | 959 | 6,648 | $320,894 | $143,480 |
| 2020 | 12 | 1,264 | 8,130 | $412,417 | $155,766 |
Total Patients
4,081
Total Services
32,586
Medicare Billing
$599,906
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 374 | 538 | $115,132 | $45,489 | 39.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 13 | 7,900 | $75,145 | $38,826 | 51.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 171 | 171 | $62,757 | $26,444 | 42.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 144 | 248 | $57,675 | $17,254 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 102 | 120 | $36,120 | $14,788 | 40.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 47 | 47 | $17,577 | $6,203 | 35.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 36 | 36 | $16,760 | $5,495 | 32.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 51 | 51 | $13,974 | $4,536 | 32.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 21 | 21 | $17,187 | $1,979 | 11.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 35 | $5,285 | $1,847 | 34.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 11 | 11 | $8,120 | $998.69 | 12.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 13 | 7,590 | $72,105 | $37,016 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 336 | 441 | $91,824 | $35,292 | 38.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 140 | 140 | $50,252 | $19,314 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 119 | 133 | $39,374 | $16,950 | 43.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 102 | 180 | $38,074 | $13,653 | 35.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 30 | 30 | $13,082 | $4,460 | 34.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 37 | 37 | $10,141 | $3,780 | 37.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 24 | 24 | $8,518 | $3,294 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 44 | $6,170 | $2,092 | 33.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 11 | 11 | $3,870 | $948.57 | 24.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 394 | 544 | $91,605 | $46,176 | 50.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 11 | 5,450 | $51,775 | $26,357 | 50.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 159 | 159 | $50,880 | $25,464 | 50.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 106 | 197 | $56,145 | $15,524 | 27.6% |
About Dr. Gautham Reddy, MD
Dr. Gautham Reddy, MD is a Electrodiagnostic Medicine healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942205653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gautham Reddy, MD has received a total of $1,118 in payments from pharmaceutical and medical device companies, with $200.89 received in 2024. These payments were reported across 48 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($817.98).
As a Medicare-enrolled provider, Reddy has provided services to 4,081 Medicare beneficiaries, totaling 32,586 services with total Medicare billing of $599,906. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Neurology
- Location Wichita, KS
- Active Since 06/17/2005
- Last Updated 04/13/2021
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1942205653
Products in Payments
- TYSABRI (Biological) $168.31
- VYEPTI (Biological) $83.09
- VYVGART (Drug) $67.38
- BRIUMVI (Drug) $58.59
- KESIMPTA (Drug) $55.54
- Pipeline (Device) $45.76
- APTIOM (Drug) $34.75
- Briviact (Drug) $26.63
- QULIPTA (Drug) $24.30
- ABRE (Device) $23.28
- NURTEC ODT (Drug) $21.02
- VYALEV (Drug) $20.22
- Omnia (Device) $19.95
- Ocrevus (Biological) $19.54
- BAFIERTAM (Drug) $19.48
- BOTOX (Biological) $19.17
- Rystiggo (Drug) $18.74
- Nourianz (Drug) $18.55
- UPLIZNA (Drug) $18.04
- ELIQUIS (Drug) $17.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Electrodiagnostic Medicine Doctors in Wichita
Dr. Paul Genilo, Md, MD
Electrodiagnostic Medicine — Payments: $701.07
Electrodiagnostic Medicine $701.07
Dr. Bart Grelinger, Md, MD
Electrodiagnostic Medicine — Payments: $566.64
Electrodiagnostic Medicine $566.64
Dr. Ty Schwertfeger, Md, MD
Electrodiagnostic Medicine — Payments: $558.24
Electrodiagnostic Medicine $558.24